false
OasisLMS
Catalog
SCCM Resource Library
Intravascular Source Control: Can Extracorporeal P ...
Intravascular Source Control: Can Extracorporeal Pathogen Clearance Impact Outcomes?
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this talk, the speaker discusses the concept of extracorporeal therapy for sepsis, which involves removing harmful substances from the bloodstream. Different approaches, such as plasma exchange, pathogen removal, cytokine absorption, and endotoxin absorption, are explored. However, the speaker highlights that the evidence for the efficacy of these therapies is limited and non-existent in some cases. Clinical trials have shown no clear benefits and potential for harm. The speaker suggests that the future focus should be on non-infectious contexts, such as trauma, cirrhosis, congestive heart failure, and renal failure. The speaker concludes that, currently, these therapies should only be used within the context of a clinical trial.
Asset Subtitle
Cardiovascular, Infection, 2023
Asset Caption
Type: one-hour concurrent | Extracorporeal Blood Purification for Shock Redux: Where Are We in 2023? (SessionID 1119343)
Meta Tag
Content Type
Presentation
Knowledge Area
Cardiovascular
Knowledge Area
Infection
Membership Level
Professional
Membership Level
Select
Tag
Extracorporeal Membrane Oxygenation ECMO
Year
2023
Keywords
extracorporeal therapy
sepsis
plasma exchange
pathogen removal
cytokine absorption
×
Please select your language
1
English